| Takeda Pharma AG - Elvanse 50 mg, Kapseln | | 63023 | | 02 | | Elvanse 50 mg | | Kapseln | | N06BA12 | | Lisdexamfetamine | | 27.03.2014 | | |
| | Composition | | lisdexamfetamini dimesilas 50 mg corresp. dexamfetaminum 14.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 133, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.2699 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Lisdexamfetamini Dimesilas | 50 mg correspond Dexamfetaminum 14.8 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lisdexamfetamini Dimesilas | 50 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Nigrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 Gélule(s) | 99.69 | 130.95 | A+ | LS | Oui |
|
|
